09.18.26 -- Patients Are Dropping Out — Here's How Sites Are Closing The Gap

Immunology trials often place a sustained burden on participants. However, integrating Home Trial Support (HTS) into a Phase 3 immunology trial can help improve the overall study experience.

Global trials often fail locally when participants face friction and unfamiliarity; however, this practical framework can reduce barriers and keep participants engaged from start to finish.

A national research network with advanced facilities, expert investigators, and diverse patients to support efficient Phase I–IV trials and speed complex protocols and enrollment.

This patient concierge team manages payments, travel, and scheduling with precision and empathy; helping sites save time, build trust, and reduce dropouts.

IQVIA One Home for Sites serves as a neutral aggregator, connector, and communicator of the key systems and tasks a clinical research site needs to perform multiple trials.

Bridge the gap between raw data and clinical enrollment. Use AI-driven insights and natural language summaries to identify the right patients faster and with greater transparency.

Discover how automated micropayments eliminate site paperwork, give participants instant access to funds, and provide trial insights.

Eliminate site payment delays and reduce clinical trial admin burden. Learn how one sponsor cut payment timelines from 120+ days to under 30 days while boosting site satisfaction.

Improve adherence, retention, and data quality in GLP-1 and cardiometabolic trials through connected digital tools, real-time symptom tracking, caregiver support, and AI-assisted review.